Ilika PLC (AIM:IKA, OTCQX:ILIKF) CEO Graeme Purdy talked with Proactive's Stephen Gunnion about the company’s full-year performance to end April and major advances across both its Stereax and Goliath battery programs.
Purdy outlined that Ilika has completed the installation of key Stereax manufacturing equipment at Cirtec Medical’s facility in Massachusetts. He confirmed that trial battery production is underway and progressing well, with alpha sample runs expected to produce validated cells for customer delivery before the end of 2025. “We've been guiding people that we should be able to start recognising revenue from customer deliveries in this calendar year,” he said.
Regarding Goliath, Purdy pointed to strong technical validation of its P1 prototype batteries, including safety test results that demonstrated inert behaviour under nail penetration. The company is now testing P1.5 prototypes, which are five times larger than previous versions. These efforts are being supported by a £1.25 million grant from the UK government’s DRIVE35 initiative, with plans to move to P2 (50Ah) prototypes by year-end.
Purdy also explained how recent fundraising has been allocated, with one-third going to Stereax activities and two-thirds supporting Goliath’s material and operating costs.
Visit Proactive’s YouTube channel for more videos, and don't forget to give the video a like, subscribe to the channel, and enable notifications for future content.
#IlikaPLC #GraemePurdy #SolidStateBatteries #Stereax #GoliathBattery #BatteryInnovation #CleanEnergy #MedicalDevices #DRIVE35 #TechTransfer #BatterySafety #EnergyStorage
